GTBP Earnings

Quarterly EPS
$-38.25
Q3 2024
$-1.67
Q4 2024
$-8.25
Q1 2025
$-273.00
Q2 2025
$26.00
Q3 2025
$-2.50
Q4 2025
$-2.75
Q1 2026
$-3.00
Q2 2026
Latest RevenueN/A
Latest Net Income-4518000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$3.000-4518000+98.9%
Q1 2026-$2.750-2833000+66.7%
Q4 2025-$2.500-23031000-49.7%
Q3 2025$26.0008.3M+168.0%
Q2 2025-$273.000-30169000-403.2%
Q1 2025-$8.250-776000+79.9%
Q4 2024-$1.670-3775000+9.7%
Q3 2024-$38.250-3411000+13.6%
Q2 2024-$54.250-3710000
Q1 2024-$41.000-2266000
Q4 2023-$1.850-2962000
Q3 2023-$44.250-2416000
GT Biopharma (GTBP) — Earnings